Publications

1. Britton CJ, Sharma V, Lohse CM, Potretzke AM, Boorjian SA, Thompson RH, Cheville JC, Leibovich BC. Incidence and predictors of ipsilateral local recurrence following partial nephrectomy. Urol Oncol. 2024 Oct; 42 (10):334.e1-334.e9 Epub 2024 June 29
   View PubMed
2. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. Reply by Authors. J Urol 2024 Oct; 212 (4):559 Epub 2024 July 30
   View PubMed
3. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. End-Stage Kidney Disease After Partial and Radical Nephrectomy Among Patients With Severe Chronic Kidney Disease. J Urol. 2024 Oct; 212 (4):550-559 Epub 2024 June 27
   View PubMed
4. Britton CJ, Sharma V, Zganjar A, Lohse CM, Cheville JC, Houston Thompson R, Leibovich BC, Boorjian SA, Potretzke AM. Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma. Urology. 2024 Aug 10 [Epub ahead of print]
   View PubMed
5. Tekin B, Cubilla AL, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience. Hum Pathol. 2024 Aug; 150:9-19 Epub 2024 June 21
   View PubMed
6. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol. 2024 Aug; 212 (2):331-341 Epub 2024 May 30
   View PubMed
7. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Reply by Authors. J Urol 2024 Aug; 212 (2):341 Epub 2024 May 30
   View PubMed
8. Allaf ME, Kim SE, Master V, McDermott DF, Harshman LC, Cole SM, Drake CG, Signoretti S, Akgul M, Baniak N, Li-Ning E, Palmer MB, Emamekhoo H, Adra N, Kaimakliotis H, Ged Y, Pierorazio PM, Abel EJ, Bilen MA, Ogan K, Moon HH, Ramaswamy KA, Singer EA, Mayer TM, Lohrey J, Margulis V, Gills J, Delacroix SE, Waples MJ, James AC, Wang P, Choueiri T, Michaelson MD, Kapoor A, Heng DY, Shuch B, Leibovich BC, Lara PN, Manola J, Maskens D, Battle D, Uzzo R, Bratslavsky G, Haas NB, Carducci MA. Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. Lancet Oncol. 2024 Aug; 25 (8):1038-1052 Epub 2024 June 25
   View PubMed
9. Deol ES, Henning G, Basourakos S, Vasdev RMS, Sharma V, Kavoussi NL, Karnes RJ, Leibovich BC, Boorjian SA, Khanna A. Artificial intelligence model for automated surgical instrument detection and counting: an experimental proof-of-concept study. Patient Saf Surg. 2024 Jul 21; 18 (1):24 Epub 2024 July 21
   View PubMed
10. Haider SA, Pressman SM, Borna S, Gomez-Cabello CA, Sehgal A, Leibovich BC, Forte AJ. Evaluating Large Language Model (LLM) Performance on Established Breast Classification Systems. Diagnostics (Basel). 2024 Jul 11; 14 (14) Epub 2024 July 11
    View PubMed
11. Myers AA, Briganti A, Leibovich B, Lerner SP, Moschini M, Roupret M, Shariat SF, Spiess PE, Stenzl A, Taneja SS, Touijer KA, Kamat AM. Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023? Eur Urol Oncol. 2024 Jun; 7 (3):412-420 Epub 2023 Nov 18
    View PubMed
12. Tekin B, Sali AP, Menon S, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Cubilla AL, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma. Hum Pathol. 2024 Jun; 148:81-86 Epub 2024 May 22
    View PubMed
13. Gomez-Cabello CA, Borna S, Pressman SM, Haider SA, Sehgal A, Leibovich BC, Forte AJ. Artificial Intelligence in Postoperative Care: Assessing Large Language Models for Patient Recommendations in Plastic Surgery. Healthcare (Basel). 2024 May 24; 12 (11)
    View PubMed
14. Borna S, Gomez-Cabello CA, Pressman SM, Haider SA, Sehgal A, Leibovich BC, Cole D, Forte AJ. Comparative Analysis of Artificial Intelligence Virtual Assistant and Large Language Models in Post-Operative Care. Eur J Investig Health Psychol Educ. 2024 May 15; 14 (5):1413-1424
    View PubMed
15. Borna S, Barry BA, Makarova S, Parte Y, Haider CR, Sehgal A, Leibovich BC, Forte AJ. Artificial Intelligence Algorithms for Expert Identification in Medical Domains: A Scoping Review. Eur J Investig Health Psychol Educ. 2024 Apr 28; 14 (5):1182-1196
    View PubMed
16. Gupta S, Dasari S, Sharma V, Atwell TD, Sivasankaran G, Smoley SA, Hardcastle JJ, Lohse CM, Tekin B, Jimenez RE, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Metastatic clear cell papillary renal cell 'tumour'. Histopathology 2024 Apr; 84 (5):905-909 Epub 2023 Dec 26
    View PubMed
17. Nielson KJ, Rowsey R, Dasari S, Sukov WR, Kipp BR, Raghunathan A, Whaley RD, Ebare K, Stanton ML, Reynolds JP, Sharma V, Thompson RH, Boorjian SA, Leibovich BC, Hernandez LH, Jimenez RE, Cheville JC, Gupta S. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study. Hum Pathol. 2024 Apr; 146:57-65 Epub 2024 Apr 12
    View PubMed
18. Joyce DD, Sharma V, Wymer KM, Moriarty JP, Borah BJ, Walia A, Costello BA, Pagliaro LC, Daneshmand S, Leibovich BC, Boorjian SA. Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma. J Natl Cancer Inst. 2024 Mar 7; 116 (3):468-475
    View PubMed
19. Dasari S, McCarthy MR, Wojcik AA, Pitel BA, Samaddar A, Tekin B, Whaley RD, Raghunathan A, Hernandez LH, Jimenez RE, Stish BJ, Thompson RH, Leibovich BC, Boorjian SA, Jeffrey Karnes R, Childs DS, Quevedo JF, Kwon ED, Pagliaro LC, Costello BA, Halling KC, Cheville JC, Kipp BR, Gupta S. Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients. Prostate Cancer Prostatic Dis. 2024 Feb 27. [Epub ahead of print]
    View PubMed
20. Pezeshki A, Cheville JC, Florio AB, Leibovich BC, Vasmatzis G. Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model. Front Immunol. 2024; 15:1356144 Epub 2024 Mar 28
    View PubMed
21. Houston Thompson R, Lohse CM, Leibovich BC, Gettman MT, Husmann DA, Viers BR. Predictors of Excellent Urology Residents at the Time of the Urology Match. Urology. 2024 Jan; 183:17-24 Epub 2023 Oct 21
    View PubMed
22. Tekin B, Cheville JC, Herrera Hernandez L, Negron V, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Cubilla AL, Whaley RD, Jimenez RE, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma. Hum Pathol. 2023 Dec; 142:42-50 Epub 2023 Nov 15
    View PubMed
23. Gilani SI, Dasari S, Tekin B, Hernandez LH, Cheville JC, Jimenez RE, Rech KL, Dao LN, Howard MT, Dalland JC, Chiu A, Theis JD, Vrana JA, Grogan M, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Dispenzieri A, McPhail ED, Gupta S. Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic disease. Hum Pathol. 2023 Dec; 142:62-67 Epub 2023 Nov 17
    View PubMed
24. Pessoa RR, Nabavizadeh R, Quevedo F, Joyce DD, Lohse CM, Sharma V, Costello BA, Boorjian SA, Thompson RH, Leibovich BC, Cheville JC. The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma. J Urol. 2023 Oct; 210 (4):611-618 Epub 2023 June 20
    View PubMed
25. Roshandel MR, Lohse CM, Sharma V, Thompson RH, Boorjian SA, Leibovich BC. Implications of Tumor Surgery in Horseshoe Kidneys: A Comparative Study of Outcomes and Surgical Practices. Urology. 2023 Sep; 179:87-94 Epub 2023 June 17
    View PubMed
26. Rodrigues Pessoa R, Zhang H, Zganjar A, Nabavizadeh R, Packiam VT, Lohse CM, Cheville JC, Pagliaro LC, Costello BA, Boorjian SA, Thompson RH, Lucien F, Dong H, Leibovich BC. Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery. Urol Oncol. 2023 Sep; 41 (9):393.e1-393.e7 Epub 2023 July 04
    View PubMed
27. Nishimura RA, Shellum JL, Anderson JR, Blackmon S, Leibovich BC. Knowledge Management in an Academic Medical Center: Providing Clinical Knowledge at the Point of Care. Mayo Clin Proc. 2023 Aug; 98 (8):1131-1136
    View PubMed
28. Asghar MS, Denic A, Mullan AF, Moustafa A, Barisoni L, Alexander MP, Stegall MD, Augustine J, Leibovich BC, Thompson RH, Rule AD. Age-Based Versus Young-Adult Thresholds for Nephrosclerosis on Kidney Biopsy and Prognostic Implications for CKD. J Am Soc Nephrol. 2023 Aug 1; 34 (8):1421-1432 Epub 2023 May 31
    View PubMed
29. Gottlich HC, Gregory AV, Sharma V, Khanna A, Moustafa AU, Lohse CM, Potretzke TA, Korfiatis P, Potretzke AM, Denic A, Rule AD, Takahashi N, Erickson BJ, Leibovich BC, Kline TL. Effect of Dataset Size and Medical Image Modality on Convolutional Neural Network Model Performance for Automated Segmentation: A CT and MR Renal Tumor Imaging Study. J Digit Imaging. 2023 Aug; 36 (4):1770-1781 Epub 2023 Mar 17
    View PubMed
30. McCarthy MR, Nichols PE, Sharma V, Stanton ML, Reynolds JP, Pitel BA, Halling KC, Lohse CM, Herrera-Hernandez L, Thompson RH, Leibovich BC, Jimenez RE, Boorjian SA, Cheville JC, Gupta S. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med. 2023 Jul 01; 147(7):817-825.
    View PubMed
31. An Z, Hsu MA, Gicobi JK, Xu T, Harrington SM, Zhang H, Pavelko KD, Hirdler JB, Lohse CM, Nabavizadeh R, Pessoa RR, Sharma V, Thompson RH, Leibovich BC, Dong H, Lucien F. A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. J Immunol. 2023 Jun 15; 210 (12):2029-2037
    View PubMed
32. Tekin B, Dasari S, Theis JD, Vrana JA, Murray DL, Oglesbee D, Thompson RH, Leibovich BC, Boorjian SA, Whaley RD, Hernandez LH, Jimenez RE, Cheville JC, Karnes RJ, Sukov WR, Gupta S. Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15. Hum Pathol. 2023 May; 135:35-44 Epub 2023 Mar 09
    View PubMed
33. Britton CJ, Andrews JR, Wallis CJD, Sharma V, Leibovich BC, Thompson RH, Boorjian SA, Bhindi B, Costello BA. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol. 2023 Mar; 41 (3):125-136 Epub 2022 Oct 28
    View PubMed
34. Lyon TD, Roussel E, Sharma V, Carames G, Lohse CM, Costello BA, Boorjian SA, Thompson RH, Joniau S, Albersen M, Leibovich BC. International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma. Eur Urol Oncol. 2023 Feb; 6 (1):76-83 Epub 2022 Dec 09
    View PubMed
35. Tekin B, Dasari S, Theis JD, Vrana JA, Murray DL, Oglesbee D, Thompson RH, Leibovich BC, Boorjian SA, Whaley RD, Herrera Hernandez L, Jimenez RE, Cheville JC, Karnes RJ, Sukov WR, Gupta S. Mass spectrometry–based assessment of prostate cancer–associated crystalloids reveals enrichment for growth and differentiation factor 15. Human Pathology. 2023; 135:35-44
    
36. Sharma V, Wymer KM, Joyce DD, Moriarty J, Khanna A, Borah BJ, Thompson RH, Costello BA, Leibovich BC, Boorjian SA. Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model. J Urol. 2023 Jan; 209 (1):89-98 Epub 2022 Sept 06
    View PubMed
37. Gupta S, Sukov WR, Vanderbilt CM, Shen W, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Cheville JC. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. Urol Oncol. 2022 Dec; 40 (12):512-524 Epub 2021 June 04
    View PubMed
38. Attia ZI, Harmon DM, Dugan J, Manka L, Lopez-Jimenez F, Lerman A, Siontis KC, Noseworthy PA, Yao X, Klavetter EW, Halamka JD, Asirvatham SJ, Khan R, Carter RE, Leibovich BC, Friedman PA. Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction. Nat Med. 2022 Dec; 28 (12):2497-2503 Epub 2022 Nov 14
    View PubMed
39. Britton CJ, Sharma V, Lohse CM, Lieske JC, Nichols PE, Khanna A, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy. Urology. 2022 Nov; 169:125-133 Epub 2022 July 22
    View PubMed
40. Tsivian M, Joyce DD, Packiam VT, Lohse CM, Boorjian SA, Potretzke TA, Chow GK, Leibovich BC, Sharma V, Thompson RH. Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors. J Urol. 2022 Nov; 208 (5):960-968 Epub 2022 June 24
    View PubMed
41. Gupta S, Nichols P, Lohse CM, Kosari F, Kattah AG, Harris FR, Karagouga G, Mehra R, Fine SW, Reuter VE, Herrera-Hernandez L, Zganjar AJ, Britton CJ, Potretzke AM, Boorjian SA, Thompson RH, Jimenez RE, Leibovich BC, Garovic VD, Cheville JC, Sharma V. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. Mayo Clin Proc. 2022 Nov; 97 (11):2050-2064 Epub 2022 June 24
    View PubMed
42. Britton CJ, Andrews JR, Wallis , C, Sharma V, Leibovich BC, Thompson R, Boorjian SA, Bhindi , B, Costello BA. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis Urologic Oncology. 2022; 41(3):125-36.
    
43. Zafar R, Schrader LJ, Cheville JC, Schoolmeester JK, Roden AC, Aubry MC, Yi ES, Raghunathan A, Herrera-Hernandez L, Thompson RH, Boorjian SA, Leibovich BC, Keeney GL, Jimenez RE, Gupta S. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma. Hum Pathol. 2022 Oct; 128:31-47. Epub 2022 Jul 06.
    View PubMed
44. Acosta PH, Panwar V, Jarmale V, Christie A, Jasti J, Margulis V, Rakheja D, Cheville J, Leibovich BC, Parker A, Brugarolas J, Kapur P, Rajaram S. Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning. Cancer Res. 2022 Aug 3; 82 (15):2792-2806
    View PubMed
45. Vinzant NJ, Christensen JM, Smith MM, Leibovich BC, Mauermann WJ. Perioperative Outcomes for Radical Nephrectomy and Level III-IV Inferior Vena Cava Tumor Thrombectomy in Patients with Renal Cell Carcinoma. J Cardiothorac Vasc Anesth. 2022 Aug; 36 (8 Pt B):3093-3100 Epub 2022 Apr 22
    View PubMed
46. Psutka SP, Gulati R, Jewett MAS, Fadaak K, Finelli A, Legere L, Morgan TM, Pierorazio PM, Allaf ME, Herrin J, Lohse CM, Houston Thompson R, Boorjian SA, Atwell TD, Schmit GD, Costello BA, Shah ND, Leibovich BC. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022 Jun; 81 (6):576-585 Epub 2021 Nov 30
    View PubMed
47. Gupta S, Farooq A, Rowsey RA, Rahman MA, Shen W, Herrera-Hernandez L, Raghunathan A, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC, Jimenez RE. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants. Hum Pathol. 2022 Jun; 124:85-95 Epub 2022 Apr 01
    View PubMed
48. Andrews JR, Lohse CM, Boorjian SA, Leibovich BC, Thompson H, Costello BA, Bhindi B. Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma. Urol Oncol. 2022 Apr; 40 (4):166.e1-166.e8 Epub 2022 Feb 13
    View PubMed
49. Gupta S, Lohse CM, Rowsey R, McCarthy MR, Shen W, Herrera-Hernandez L, Boorjian SA, Houston Thompson R, Jimenez RE, Leibovich BC, Cheville JC. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome. Eur Urol. 2022 Mar; 81 (3):229-233 Epub 2021 Dec 06
    View PubMed
50. Xie Z, Yadav S, Lohse CM, Cheville JC, Pagliaro LC, Shah PH, Boorjian SA, Thompson H, Leibovich BC, Costello BA. Collecting duct carcinoma: A single-institution retrospective study. Urol Oncol. 2022 Jan; 40 (1):13.e9-13.e18 Epub 2021 Nov 06
    View PubMed
51. Gupta S, Erickson LA, Lohse CM, Shen W, Pitel BA, Knight SM, Halling KC, Herrera-Hernandez L, Boorjian SA, Thompson RH, Leibovich BC, Jimenez RE, Cheville JC. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA Netw Open. 2021 Nov 1; 4 (11):e2132615 Epub 2021 Nov 01
    View PubMed
52. Klett DE, Tsivian M, Packiam VT, Lohse CM, Ahmed ME, Potretzke TA, Gopalakrishna A, Boorjian SA, Thompson RH, Leibovich BC, Potretzke AM. Partial versus radical nephrectomy in clinical T2 renal masses. Int J Urol. 2021 Nov; 28 (11):1149-1154 Epub 2021 Aug 11
    View PubMed
53. Ricaurte Archila L, Denic A, Mullan AF, Narasimhan R, Bogojevic M, Thompson RH, Leibovich BC, Sangaralingham SJ, Smith ML, Alexander MP, Rule AD. A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor. J Am Soc Nephrol. 2021 Oct; 32 (10):2623-2633 Epub 2021 June 18
    View PubMed
54. Kravtsov O, Gupta S, Cheville JC, Sukov WR, Rowsey R, Herrera-Hernandez LP, Lohse CM, Knudson R, Leibovich BC, Jimenez RE. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics. Hum Pathol. 2021 Aug; 114:9-18 Epub 2021 May 04
    View PubMed
55. Gupta S, Jimenez RE, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. Mayo Clin Proc. 2021 Jun; 96 (6):1470-1489 Epub 2021 Jan 29
    View PubMed
56. Freitag CE, Sukov WR, Bryce AH, Berg JV, Vanderbilt CM, Shen W, Smadbeck JB, Greipp PT, Ketterling RP, Jenkins RB, Herrera-Hernandez L, Costello BA, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Murphy SJ, Vasmatzis G, Cheville JC, Gupta S. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing. Hum Pathol. 2021 Jun; 112:20-34 Epub 2021 Mar 31
    View PubMed
57. Breau RH, Fergusson DA, Knoll G, McAlpine K, Morash C, Cnossen S, Lavallee LT, Mallick R, Finelli A, Jewett MAS, Leibovich BC, Cook JA, Kapoor A, Pouliot F, Izawa J, Rendon R, Cagiannos I. Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled Trial. J Urol. 2021 May; 205 (5):1303-1309 Epub 2020 Dec 21
    View PubMed
58. Dubey D, Kryzer T, Guo Y, Clarkson B, Cheville JC, Costello BA, Leibovich BC, Algeciras-Schimnich A, Lucchinnetti C, Hammami MB, Knight AM, Howe C, Lennon VA, McKeon A, Pittock SJ. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker. Ann Neurol. 2021 May; 89(5):1001-1010. Epub 2021 Feb 28.
    View PubMed
59. Rini B, Abel EJ, Albiges L, Bex A, Brugarolas J, Bukowski RM, Coleman JA, Drake CG, Figlin RA, Futreal A, Hammers H, Powles T, Rathmell WK, Ricketts CJ, Turajlic S, Wood CG, Leibovich BC. Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure. Clin Genitourin Cancer. 2021 Apr; 19 (2):167-175 Epub 2020 Nov 14
    View PubMed
60. Bearrick EN, Packiam V, Bhindi B, Lohse CM, Cheville JC, Mason RJ, Tollefson M, Harrington S, Dong H, Parker AS, Boorjian SA, Thompson RH, Leibovich BC. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. Urol Oncol. 2021 Feb; 39 (2):135.e1-135.e8 Epub 2020 Dec 09
    View PubMed
61. Avulova S, Cheville JC, Lohse CM, Gupta S, Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC, Potretzke AM. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. 2021 Feb; 79 (2):225-231 Epub 2020 Nov 07
    View PubMed
62. Bhindi B, Bearrick EN, Cheville JC, Lohse CM, Mason RJ, Shah P, Harrington S, Zhang H, Dong H, Boorjian SA, Thompson RH, Leibovich BC. Bim expression in peritumoral lymphocytes is associated with survival in patients with metastatic clear cell renal cell carcinoma Kidney Cancer. 2021; 5 (3):129-35
    
63. Gupta S, Cheville JC, Galeano BK, Sukov WR, Herrera-Hernandez L, Reed KA, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE. Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol. 2021 Jan; 107:46-57 Epub 2020 Nov 06
    View PubMed
64. Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429
    View PubMed
65. Denic A, Elsherbiny H, Mullan AF, Leibovich BC, Thompson RH, Ricaurte Archila L, Narasimhan R, Kremers WK, Alexander MP, Lieske JC, Lerman LO, Rule AD. Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function. J Am Soc Nephrol. 2020 Nov; 31 (11):2642-2652 Epub 2020 Sept 16
    View PubMed
66. Eckel-Passow JE, Yan H, Kosel ML, Serie D, Decker PA, Jenkins RB, Costello B, Leibovich B, Ho TH, Parker A. 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness. BMC Urol. 2020 Oct 29; 20 (1):173
    View PubMed
67. Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients. Hum Pathol. 2020 Sep; 103:1-13 Epub 2020 July 15
    View PubMed
68. Marion JT, Schmitz JJ, Schmit GD, Kurup AN, Welch BT, Pasternak JJ, Boorjian SA, Leibovich BC, Atwell TD, Thompson RH. Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation. J Vasc Interv Radiol. 2020 Aug; 31 (8):1249-1255 Epub 2020 May 23
    View PubMed
69. McGarrah PW, Westin GFM, Hobday TJ, Scales JA, Ingimarsson JP, Leibovich BC, Halfdanarson TR. Renal Neuroendocrine Neoplasms: A Single-center Experience. Clin Genitourin Cancer. 2020 Aug; 18 (4):e343-e349 Epub 2019 Dec 05
    View PubMed
70. Ziegelmann M, Joseph J, Glasgow A, Tyson M, Pak R, Gazelka H, Leibovich B, Habermann E, Gettman M. Comparison of prescribing patterns before and after implementation of evidence-based opioid prescribing guidelines for the postoperative urologic surgery patient. Am J Surg. 2020 Aug; 220 (2):499-504 Epub 2019 Dec 06
    View PubMed
71. Leibovich BC, Lohse CM, Cheville JC, Potretzke TA, Tsivian M, Shah PH, Boorjian SA, Thompson RH, Lyon TD. Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? Kidney Cancer. 2020; 4(2):111-115.
    
72. Packiam VT, Tsivian M, Lohse CM, Cheville JC, Boorjian SA, Houston Thompson R, Leibovich BC. Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal masses. Urol Oncol. 2020 Jul; 38 (7):640.e13-640.e22 Epub 2020 May 10
    View PubMed
73. Yang DY, Potretzke TA, Miest TS, Bhindi B, Lohse CM, Cheville JC, King BF, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy. Int J Urol. 2020 Jul; 27 (7):618-622 Epub 2020 May 18
    View PubMed
74. Bacic J, Liu T, Thompson RH, Boorjian SA, Leibovich BC, Golijanin D, Gershman B. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma. Urology. 2020 Jun; 140:98-106 Epub 2020 Mar 04
    View PubMed
75. Bhindi B, Asante D, Branda ME, Hickson LJ, Mason RJ, Jeffery MM, Boorjian SA, Leibovich BC, Thompson RH. Survival outcomes for patients with surgically induced end-stage renal disease. Can Urol Assoc J. 2020 Mar; 14 (3):E65-E73 Epub 2019 Sept 27
    View PubMed
76. Eckel-Passow JE, Ho TH, Serie DJ, Cheville JC, Houston Thompson R, Costello BA, Dong H, Kwon ED, Leibovich BC, Parker AS. Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma. Cancer Med. 2020 Feb; 9 (3):1152-1160 Epub 2019 Dec 12
    View PubMed
77. Packiam VT, Tyson Ii MD, Tsivian M, Lohse CM, Boorjian SA, Cheville JC, Costello BA, Leibovich BC, Thompson RH. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. Urol Oncol. 2020 Feb; 38 (2):41.e19-41.e27 Epub 2019 Nov 21
    View PubMed
78. Lyon TD, Thompson RH, Shah PH, Lohse CM, Boorjian SA, Costello BA, Cheville JC, Leibovich BC. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era. J Urol. 2020 Feb; 203 (2):275-282 Epub 2019 Aug 08
    View PubMed
79. Joseph JP, Potretzke TA, Packiam V, Sharma V, Toussi A, Miest TS, Juvet T, Boorjian SA, Thompson RH, Welle CL, Atwell TD, Leibovich BC, Tollefson MK, Potretzke AM. Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma. Urology. 2020 Jan; 135:95-100 Epub 2019 Oct 23
    View PubMed
80. Golijanin B, Pereira J, Mueller-Leonhard C, Golijanin D, Amin A, Mega A, Boorjian SA, Thompson RH, Leibovich BC, Gershman B. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. Urol Oncol. 2019 Dec; 37 (12):932-940 Epub 2019 Sept 27
    View PubMed
81. Gershman B, Leibovich BC, Kim SP. Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass. Eur Urol Focus. 2019 Nov; 5 (6):970-972 Epub 2019 Feb 15
    View PubMed
82. Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms. Urology. 2019 Nov; 133:145-150 Epub 2019 July 26
    View PubMed
83. Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, Deyle DR, Federspiel MJ, Fielding A, Galanis E, Lacy MQ, Leibovich BC, Liu MC, Munoz-Alia M, Miest TC, Molina JR, Mueller S, Okuno SH, Packiriswamy N, Peikert T, Raffel C, Van Rhee F, Ungerechts G, Young PR, Zhou Y, Peng KW. Oncolytic Measles Virotherapy and Opposition to Measles Vaccination. Mayo Clin Proc. 2019 Sep; 94 (9):1834-1839 Epub 2019 June 22
    View PubMed
84. Gupta S, Cheville JC, Jungbluth AA, Zhang Y, Zhang L, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Blum KA, Lohse CM, Hakimi AA, Thompson RH, Leibovich BC, Berger MF, Arcila ME, Ross DS, Ladanyi M, Antonescu CR, Reuter VE. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management. Mod Pathol. 2019 Sep; 32 (9):1344-1358 Epub 2019 Apr 17
    View PubMed
85. Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Hum Pathol. 2019 Sep; 91:114-122 Epub 2019 July 09
    View PubMed
86. Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Roupret M, Abufaraj M, Foerster B, Gonen M, Shariat SF. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma. World J Urol. 2019 Aug; 37 (8):1631-1637 Epub 2018 Nov 07
    View PubMed
87. Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol. 2019 Aug; 76 (2):244-251 Epub 2019 May 03
    View PubMed
88. Porta C, Cosmai L, Leibovich BC, Powles T, Gallieni M, Bex A. The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nat Rev Nephrol. 2019 Jul; 15 (7):423-433
    View PubMed
89. Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA. Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. J Urol. 2019 Jul; 202 (1):69-75 Epub 2019 June 07
    View PubMed
90. Toussi A, Agarwal D, Leibovich B, Potretzke A. Percutaneous resection of metastatic renal cell carcinoma. Int Braz J Urol 2019 May-Jun; 45 (3):640
    View PubMed
91. Patel HD, Puligandla M, Shuch BM, Leibovich BC, Kapoor A, Master VA, Drake CG, Heng DY, Lara PN, Choueiri TK, Maskens D, Singer EA, Eggener SE, Svatek RS, Stadler WM, Cole S, Signoretti S, Gupta RT, Michaelson MD, McDermott DF, Cella D, Wagner LI, Haas NB, Carducci MA, Harshman LC, Allaf ME. The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? Future Oncol. 2019 May; 15 (15):1683-1695 Epub 2019 Apr 10
    View PubMed
92. Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. Eur Urol. 2019 May; 75 (5):766-772 Epub 2018 Nov 23
    View PubMed
93. Boswell TC, Sharma V, Westerman ME, Dean PG, Chow GK, Thompson RH, Leibovich BC, Boorjian SA. Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer. Urology. 2019 Apr; 126:134-139 Epub 2019 Jan 12
    View PubMed
94. Shenoy N, Bhagat TD, Cheville J, Lohse C, Bhattacharyya S, Tischer A, Machha V, Gordon-Mitchell S, Choudhary G, Wong LF, Gross L, Ressigue E, Leibovich B, Boorjian SA, Steidl U, Wu X, Pradhan K, Gartrell B, Agarwal B, Pagliaro L, Suzuki M, Greally JM, Rakheja D, Thompson RH, Susztak K, Witzig T, Zou Y, Verma A. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma. J Clin Invest. 2019 Mar 4; 129 (4):1612-1625 Epub 2019 Mar 04
    View PubMed
95. Atwell TD, Schultz GG, Leibovich BC, Schmit GD, Boorjian SA, Kurup AN, Thompson RH, Yost KJ. Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience. AJR Am J Roentgenol. 2019 Mar; 212 (3):672-676 Epub 2019 Jan 08
    View PubMed
96. Ouzaid I, Capitanio U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, Van Poppel H, Bensalah K, Young Academic Urologists Kidney Cancer Working Group of the European Association of Urology. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. Eur Urol Oncol. 2019 Mar; 2 (2):141-149 Epub 2018 Sept 24
    View PubMed
97. Ziegelmann MJ, Joseph JP, Glasgow AE, Tyson MD, Pak RW, Gazelka HM, Schatz AL, Leibovich BC, Habermann EB, Gettman MT. Wide Variation in Opioid Prescribing After Urological Surgery in Tertiary Care Centers. Mayo Clin Proc. 2019 Feb; 94 (2):262-274
    View PubMed
98. Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma. BJU Int. 2019 Feb; 123 (2):270-276 Epub 2018 Sept 09
    View PubMed
99. Breau RH, Cagiannos I, Knoll G, Morash C, Cnossen S, Lavallee LT, Mallick R, Finelli A, Jewett M, Leibovich BC, Cook J, LeBel L, Kapoor A, Pouliot F, Izawa J, Rendon R, Fergusson DA. Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol. BMJ Open. 2019 Jan 3; 9 (1):e025662 Epub 2019 Jan 03
    View PubMed
100. Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, Timpson NJ, Haycock PC, Brown KM, Wang Z, Ye Y, Hofmann JN, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Garnier JG, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Radojevic-Skodric S, Ognjanovic S, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Benhamou S, Cancel-Tassin G, Cussenot O, Weiderpass E, Ljungberg B, Tumkur Sitaram R, Haggstrom C, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Andreotti G, Beane Freeman LE, Koutros S, Mannisto S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Wilson KM, Gaziano JM, Sesso HD, Freedman ND, Parker AS, Eckel-Passow JE, Huang WY, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Lathrop GM, Deleuze JF, Gunter M, McKay JD, Wu X, Houlston RS, Chanock SJ, Relton C, Richards JB, Martin RM, Davey Smith G, Brennan P. The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study. PLoS Med. 2019 Jan; 16 (1):e1002724 Epub 2019 Jan 03
     View PubMed
101. Schmit C, Matsumoto J, Yost K, Alexander A, Ness L, Kurup AN, Atwell T, Leibovich B, Schmit G. Impact of a 3D printed model on patients' understanding of renal cryoablation: a prospective pilot study. Abdom Radiol (NY). 2019 Jan; 44(1):304-309.
     View PubMed
102. Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT. Predictors of Urology Resident Surgical Skills, Clinical Communication Skills, Common Sense and In-Service Scores. Urol Pract. 2019 Jan; 6 (1):52-57 Epub 2017 Dec 29
     View PubMed
103. Kriegmair MC, Bertolo R, Karakiewicz PI, Leibovich BC, Ljungberg B, Mir MC, Ouzaid I, Salagierski M, Staehler M, van Poppel H, Wood CC, Capitanio U, Young Academic Urologists Kidney Cancer working group of the European Association of Urology. Systematic Review of the Management of Local Kidney Cancer Relapse. Eur Urol Oncol. 2018 Dec; 1 (6):512-523 Epub 2018 July 13
     View PubMed
104. Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. Eur Urol. 2018 Dec; 74 (6):825-832 Epub 2018 Sept 24
     View PubMed
105. Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. Urol Oncol. 2018 Nov; 36 (11):499.e1-499.e7 Epub 2018 Sept 15
     View PubMed
106. Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018 Nov; 200 (5):981-988 Epub 2018 May 22
     View PubMed
107. Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, Potretzke AM, Hartman RP, Potretzke TA, Boorjian SA, Cheville JC, Leibovich BC. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. Eur Urol. 2018 Oct; 74 (4):489-497 Epub 2018 July 13
     View PubMed
108. Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT. Predictors of Scholarly Productivity, Pursuit of Fellowship, and Academic Practice Among Urology Residents Using Medical Student Application Materials. Urology. 2018 Oct; 120:49-55 Epub 2018 July 19
     View PubMed
109. Bhindi B, Habermann EB, Mason RJ, Costello BA, Pagliaro LC, Thompson RH, Leibovich BC, Boorjian SA. Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma. J Urol. 2018 Sep; 200 (3):528-534 Epub 2018 Mar 21
     View PubMed
110. Wallis CJD, Klaassen Z, Bhindi B, Ye XY, Chandrasekar T, Farrell AM, Goldberg H, Boorjian SA, Leibovich B, Kulkarni GS, Shah PS, Bjarnason GA, Heng DYC, Satkunasivam R, Finelli A. First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. Eur Urol. 2018 Sep; 74 (3):309-321 Epub 2018 Apr 13
     View PubMed
111. Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, Froehling D, Leibovich BC, Viers BR. Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. J Urol. 2018 Sep; 200 (3):520-527 Epub 2018 Apr 27
     View PubMed
112. Mason RJ, Atwell T, Lohse C, Bhindi B, Schmit G, Schmitz J, Leibovich BC, Boorjian SA, Thompson RH. Synchronous nephron-sparing approaches for bilateral renal masses: peri-operative and renal functional outcomes. BJU Int. 2018 Aug; 122 (2):243-248 Epub 2018 Apr 29
     View PubMed
113. Denic A, Mathew J, Nagineni VV, Thompson RH, Leibovich BC, Lerman LO, Lieske JC, Alexander MP, Augustine JJ, Kremers WK, Rule AD. Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume. J Am Soc Nephrol. 2018 Jul; 29 (7):1960-1969 Epub 2018 May 22
     View PubMed
114. Barbara DW, Broski SM, Leibovich BC, Mauermann WJ. Inferior vena cava tumour thrombus and renal cell carcinoma. Can J Anaesth. 2018 May; 65 (5):588-589 Epub 2017 Nov 01
     View PubMed
115. Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol. 2018 May; 199 (5):1143-1148 Epub 2017 Dec 07
     View PubMed
116. Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V. The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. Urology. 2018 May; 115:119-124 Epub 2018 Feb 27
     View PubMed
117. Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int. 2018 May; 121 (5):684-698 Epub 2018 Mar 01
     View PubMed
118. Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. Eur Urol. 2018 May; 73 (5):772-780 Epub 2018 Feb 03
     View PubMed
119. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2018 Mar; 73 (3):469-475 Epub 2017 Nov 11
     View PubMed
120. Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS. Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma. Int J Cancer. 2018 Feb 15; 142 (4):747-756 Epub 2017 Oct 28
     View PubMed
121. Figlin RA, Leibovich BC, Stewart GD, Negrier S. Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success? Ann Oncol. 2018 Feb 1; 29 (2):324-331
     View PubMed
122. Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, Weisbrod AJ, Schmit GD, Thompson RH. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. Eur Urol. 2018 Feb; 73 (2):254-259 Epub 2017 Sept 28
     View PubMed
123. Stewart GD, Leibovich BC, Negrier S, Figlin RA. Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights. J Clin Oncol 2017 Dec 10; 35 (35):3895-3897 Epub 2017 Oct 25
     View PubMed
124. Atwell TD, Kurup AN, Boorjian SA, Schmitz JJ, Thompson RH, Leibovich BC, Schmit GD. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging. J Vasc Interv Radiol. 2017 Dec; 28 (12):1651-1657 Epub 2017 Oct 16
     View PubMed
125. Bhindi B, Carlson RE, Mason RJ, Schulte PJ, Gettman MT, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Leibovich BC, Karnes RJ. Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin. Urology. 2017 Nov; 109:145-152 Epub 2017 Aug 18
     View PubMed
126. Bhindi B, Lohse CM, Mason RJ, Westerman ME, Cheville JC, Tollefson MK, Boorjian SA, Thompson RH, Leibovich BC. Are We Using the Best Tumor Size Cut-points for Renal Cell Carcinoma Staging? Urology. 2017 Nov; 109:121-126 Epub 2017 Apr 12
     View PubMed
127. Thompson RH, Lohse CM, Husmann DA, Leibovich BC, Gettman MT. Predictors of a Successful Urology Resident Using Medical Student Application Materials. Urology. 2017 Oct; 108:22-28 Epub 2017 July 24
     View PubMed
128. Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, Leibovich BC, Schmit GD, Thompson RH. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. BJU Int. 2017 Oct; 120 (4):544-549 Epub 2017 June 19
     View PubMed
129. Yang DY, Thompson RH, Zaid HB, Lohse CM, Rule AD, Boorjian SA, Leibovich BC, Cheville JC, Tollefson MK. Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy. J Urol. 2017 Oct; 198 (4):795-802 Epub 2017 Apr 08
     View PubMed
130. Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Arnold ML, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS. Coffee consumption and risk of renal cell carcinoma. Cancer Causes Control. 2017 Aug; 28 (8):857-866 Epub 2017 June 24
     View PubMed
131. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol. 2017 Aug; 72 (2):300-306 Epub 2017 Jan 13
     View PubMed
132. Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol. 2017 Jul; 30 (7):998-1012 Epub 2017 Mar 24
     View PubMed
133. Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Mark Lathrop G, Rothman N, Deleuze JF, McKay JD, Parker AS, Wu X, Houlston RS, Brennan P, Chanock SJ. Genome-wide association study identifies multiple risk loci for renal cell carcinoma. Nat Commun. 2017 Jun 9; 8:15724 Epub 2017 June 09
     View PubMed
134. Serie DJ, Joseph RW, Cheville JC, Ho TH, Parasramka M, Hilton T, Thompson RH, Leibovich BC, Parker AS, Eckel-Passow JE. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. Eur Urol. 2017 Jun; 71 (6):979-985 Epub 2016 Nov 26
     View PubMed
135. Bhindi B, Thompson RH, Mason RJ, Haddad MM, Geske JR, Kurup AN, Hannon JD, Boorjian SA, Leibovich BC, Atwell TD, Schmit GD. Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort. BJU Int. 2017 Jun; 119 (6):905-912 Epub 2017 Apr 09
     View PubMed
136. Leng S, Takahashi N, Gomez Cardona D, Kitajima K, McCollough B, Li Z, Kawashima A, Leibovich BC, McCollough CH. Subjective and objective heterogeneity scores for differentiating small renal masses using contrast-enhanced CT. Abdom Radiol (NY). 2017 May; 42 (5):1485-1492
     View PubMed
137. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Tollefson MK, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2017 Apr; 71 (4):560-567 Epub 2016 Sept 24
     View PubMed
138. Bailey GC, Boorjian SA, Ziegelmann MJ, Westerman ME, Lohse CM, Leibovich BC, Cheville JC, Thompson RH. Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma. BJU Int. 2017 Apr; 119 (4):585-590 Epub 2016 Oct 20
     View PubMed
139. Capitanio U, Leibovich BC. The rationale and the role of lymph node dissection in renal cell carcinoma. World J Urol. 2017 Apr; 35 (4):497-506 Epub 2016 June 30
     View PubMed
140. Parker WP, Cheville JC, Frank I, Zaid HB, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. Eur Urol. 2017 Apr; 71 (4):665-673 Epub 2016 June 07
     View PubMed
141. Zaid HB, Parker WP, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Patient factors associated with 30-day complications after partial nephrectomy: A contemporary update. Urol Oncol. 2017 Apr; 35 (4):153.e1-153.e6 Epub 2016 Dec 06
     View PubMed
142. Eckel-Passow JE, Serie DJ, Cheville JC, Ho TH, Kapur P, Brugarolas J, Thompson RH, Leibovich BC, Kwon ED, Joseph RW, Parker AS. BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor. BMC Urol. 2017 Mar 21; 17 (1):19
     View PubMed
143. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis. J Urol. 2017 Mar; 197 (3 Pt 1):574-579 Epub 2016 Sept 20
     View PubMed
144. Pham MN, Apolo AB, De Santis M, Galsky MD, Leibovich BC, Pisters LL, Siefker-Radtke AO, Sonpavde G, Steinberg GD, Sternberg CN, Tagawa ST, Weizer AZ, Woods ME, Milowsky MI. Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World J Urol. 2017 Mar; 35 (3):367-378 Epub 2016 June 24
     View PubMed
145. Ho TH, Serie DJ, Parasramka M, Cheville JC, Bot BM, Tan W, Wang L, Joseph RW, Hilton T, Leibovich BC, Parker AS, Eckel-Passow JE. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes. Ann Oncol. 2017 Mar 1; 28 (3):604-610
     View PubMed
146. Parker WP, Lohse CM, Zaid HB, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma. Urol Oncol. 2017 Jan; 35 (1):36.e1-36.e6 Epub 2016 Sept 27
     View PubMed
147. Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Urol. 2017 Jan; 197 (1):44-49 Epub 2016 July 26
     View PubMed
148. Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. BJU Int. 2017 Jan; 119 (1):116-127 Epub 2016 Aug 31
     View PubMed
149. Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-Merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. Urology. 2017 Jan; 99:155-161 Epub 2016 Aug 17
     View PubMed
150. Westerman ME, Matsumoto JM, Morris JM, Leibovich BC. Three-dimensional Printing for Renal Cancer and Surgical Planning. Eur Urol Focus. 2016 Dec 15; 2 (6):574-576 Epub 2017 Jan 19
     View PubMed
151. Parker WP, Boorjian SA, Zaid HB, Cheville JC, Leibovich BC, Thompson RH. Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma. Eur Urol Focus. 2016 Dec 15; 2 (6):625-630 Epub 2016 July 07
     View PubMed
152. Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW. Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death. Eur Urol Focus. 2016 Dec 15; 2 (6):608-615 Epub 2016 Apr 02
     View PubMed
153. Viers BR, Thompson RH, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Tollefson MK. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors. World J Urol. 2016 Dec; 34 (12):1693-1699 Epub 2016 Apr 06
     View PubMed
154. Gershman B, Takahashi N, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int. 2016 Nov; 118 (5):742-749 Epub 2016 Feb 23
     View PubMed
155. Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT. AJR Am J Roentgenol. 2016 Nov; 207 (5):1031-1038 Epub 2016 Aug 24
     View PubMed
156. Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016 Oct; 34 (10):1465-72 Epub 2016 Feb 25
     View PubMed
157. Psutka SP, Cheville JC, Costello BA, Stewart-Merrill SB, Lohse CM, Leibovich BC, Boorjian SA, Thompson RH. Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma. Urology. 2016 Oct; 96:106-113 Epub 2016 July 21
     View PubMed
158. Russell CM, Lue K, Fisher J, Kassouf W, Schwaab T, Sexton WJ, Tanguay S, Psutka SP, Thompson RH, Leibovich BC, Hanzly MI, Spiess PE, Boorjian SA. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma. BJU Int. 2016 Jun; 117: (6B)E60-6.
     View PubMed
159. Gershman B, Psutka SP, Matsumoto JM, King BF, Kawashima A, Morris JM, Leibovich BC. Use of Personalized Printed 3-Dimensional Kidney Models for Simulation before Nephron Sparing Surgery: Methodology and Examples from a Case Series. Urol Pract. 2016 Mar; 3 (2):124-133 Epub 2015 Dec 21
     View PubMed
160. Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. J Urol. 2016 Feb; 195 (2):270-6 Epub 2015 Aug 18
     View PubMed
161. Gershman B, Psutka SP, Matsumoto JM, King BF, Kawashima A, Morris JM, Leibovich BC. Use of personalized printed 3-dimensional kidney models for simulation before nephron sparing surgery: methodology and examples from a case series Urology Practice. 2016; 3: (2)124-33.
     
162. Gershman B, Moreira DM, Boorjian SA, Lohse CM, Cheville JC, Costello BA, Leibovich BC, Thompson RH. Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. Eur Urol. 2016 Jan; 69 (1):84-91 Epub 2015 June 01
     View PubMed
163. Rini BI, McDermott DF, Hammers H, Bro W, Bukowski RM, Faba B, Faba J, Figlin RA, Hutson T, Jonasch E, Joseph RW, Leibovich BC, Olencki T, Pantuck AJ, Quinn DI, Seery V, Voss MH, Wood CG, Wood LS, Atkins MB. Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma. J Immunother Cancer. 2016; 4:81 Epub 2016 Nov 15
     View PubMed
164. Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Frank I. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. J Clin Oncol. 2015 Dec 10; 33 (35):4151-7 Epub 2015 Sept 08
     View PubMed
165. Moreira DM, Gershman B, Thompson RH, Okuno SH, Robinson SI, Leibovich BC, Boorjian SA. Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based study. Urol Oncol. 2015 Dec; 33: (12)505.e15-20.
     View PubMed
166. Takahashi N, Leng S, Kitajima K, Gomez-Cardona D, Thapa P, Carter RE, Leibovich BC, Sasiwimonphan K, Sasaguri K, Kawashima A. Small (< 4 cm) Renal Masses: Differentiation of Angiomyolipoma Without Visible Fat From Renal Cell Carcinoma Using Unenhanced and Contrast-Enhanced CT. AJR Am J Roentgenol. 2015 Dec; 205(6):1194-202.
     View PubMed
167. Sasaguri K, Takahashi N, Gomez-Cardona D, Leng S, Schmit GD, Carter RE, Leibovich BC, Kawashima A. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT. AJR Am J Roentgenol. 2015 Nov; 205: (5)999-1007.
     View PubMed
168. Tan W, Boorjian S, Advani P, Farmer S, Lohse C, Cheville J, Kwon E, Leibovich B. The Estrogen Pathway: Estrogen Receptor-alpha, Progesterone Receptor, and Estrogen Receptor-beta Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens. Clin Genitourin Cancer. 2015 Oct; 13 (5):476-84 Epub 2015 Apr 15
     View PubMed
169. Gustafson MP, Lin Y, Bleeker JS, Warad D, Tollefson MK, Crispen PL, Bulur PA, Harrington SM, Laborde RR, Gastineau DA, Leibovich BC, Cheville JC, Kwon ED, Dietz AB. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2015 Sep 15; 21 (18):4224-33 Epub 2015 May 21
     View PubMed
170. Psutka SP, Boorjian SA, Thompson RH, Schmit GD, Schmitz JJ, Bower TC, Stewart SB, Lohse CM, Cheville JC, Leibovich BC. Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int. 2015 Sep; 116 (3):388-96 Epub 2015 Mar 23
     View PubMed
171. Haddad AQ, Leibovich BC, Abel EJ, Luo JH, Krabbe LM, Thompson RH, Heckman JE, Merrill MM, Gayed BA, Sagalowsky AI, Boorjian SA, Wood CG, Margulis V. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus. Urol Oncol. 2015 Sep; 33: (9)388.e1-9.
     View PubMed
172. Viers BR, Houston Thompson R, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK, Boorjian SA. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy. Urol Oncol. 2015 Sep; 33 (9):388.e11-8 Epub 2015 Feb 17
     View PubMed
173. Psutka SP, Leibovich BC. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Ther Adv Urol. 2015 Aug; 7 (4):216-29
     View PubMed
174. Zhang BY, Cheville JC, Thompson RH, Lohse CM, Boorjian SA, Leibovich BC, Costello BA. Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma. Eur Urol. 2015 Jul; 68 (1):5-7 Epub 2015 Jan 28
     View PubMed
175. Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, Weisbrod AJ, Lohse CM, Hartman WR, Stockland AH, Leibovich BC, Schmit GD, Thompson RH. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol. 2015 Jun; 26 (6):792-9 Epub 2015 Mar 29
     View PubMed
176. Saksena A, Aho J, Winocour S, Maricevich R, Senchenkov A, Rose P, Leibovich B, Zietlow S, Saint-Cyr M. Combination of a fillet flap, free tissue transfer, and autologous tissue grafts in pelvic reconstruction following retroperitoneal sarcoma: a case report. Microsurgery. 2015 May; 35 (4):320-3 Epub 2014 Nov 08
     View PubMed
177. Smaldone MC, Handorf E, Kim SP, Thompson RH, Costello BA, Corcoran AT, Wong YN, Uzzo RG, Leibovich BC, Kutikov A, Boorjian SA. Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer Database. J Urol. 2015 Apr; 193 (4):1108-13 Epub 2014 Oct 23
     View PubMed
178. Zhang BY, Thompson RH, Lohse CM, Leibovich BC, Boorjian SA, Cheville JC, Costello BA. A novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int. 2015 Mar; 115 (3):405-11 Epub 2014 Oct 19
     View PubMed
179. Psutka SP, Boorjian SA, Lohse CM, Stewart SB, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. Urol Oncol. 2015 Feb; 33 (2):67.e15-23 Epub 2014 Aug 19
     View PubMed
180. Thompson RH, Atwell T, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Psutka SP, Stewart SB, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015 Feb; 67 (2):252-9 Epub 2014 Aug 06
     View PubMed
181. McDermott DF, Cheng SC, Signoretti S, Margolin KA, Clark JI, Sosman JA, Dutcher JP, Logan TF, Curti BD, Ernstoff MS, Appleman L, Wong MK, Khushalani NI, Oleksowicz L, Vaishampayan UN, Mier JW, Panka DJ, Bhatt RS, Bailey AS, Leibovich BC, Kwon ED, Kabbinavar FF, Belldegrun AS, Figlin RA, Pantuck AJ, Regan MM, Atkins MB. The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2015 Feb 1; 21 (3):561-8 Epub 2014 Nov 25
     View PubMed
182. Psutka SP, Kim SP, Gross CP, Van Houten H, Thompson RH, Abouassaly R, Weight C, Boorjian SA, Leibovich BC, Shah ND. The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization. Urology. 2015 Feb; 85 (2):442-50
     View PubMed
183. Cheney SM, Andrews PE, Leibovich BC, Castle EP. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. BJU Int. 2015 Jan; 115 (1):114-20 Epub 2014 Aug 16
     View PubMed
184. Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA, Leibovich BC. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. J Clin Oncol. 2014 Dec 20; 32 (36):4059-65 Epub 2014 Nov 17
     View PubMed
185. Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. J Urol. 2014 Dec; 192 (6):1620-7 Epub 2014 June 12
     View PubMed
186. Davidiuk AJ, Parker AS, Thomas CS, Leibovich BC, Castle EP, Heckman MG, Custer K, Thiel DD. Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy. Eur Urol. 2014 Dec; 66 (6):1165-71 Epub 2014 Sept 02
     View PubMed
187. Viers BR, Houston Thompson R, Boorjian SA, Lohse CM, Leibovich BC, Tollefson MK. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. Urol Oncol. 2014 Nov; 32 (8):1277-84 Epub 2014 July 10
     View PubMed
188. Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Eur Urol. 2014 Nov; 66 (5):929-35 Epub 2013 Dec 25
     View PubMed
189. Haddad AQ, Wood CG, Abel EJ, Krabbe LM, Darwish OM, Thompson RH, Heckman JE, Merril MM, Gayed BA, Sagalowsky AI, Boorjian SA, Margulis V, Leibovich BC. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J Urol. 2014 Oct; 192 (4):1050-6 Epub 2014 Apr 02
     View PubMed
190. Weingarten TN, Del Mundo SB, Yeoh TY, Scavonetto F, Leibovich BC, Sprung J. Hospitalization for partial nephrectomy was not associated with intrathecal opioid analgesia: Retrospective analysis. Saudi J Anaesth. 2014 Oct; 8 (4):517-22
     View PubMed
191. Abel EJ, Thompson RH, Margulis V, Heckman JE, Merril MM, Darwish OM, Krabbe LM, Boorjian SA, Leibovich BC, Wood CG. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. 2014 Sep; 66 (3):584-92 Epub 2013 Nov 07
     View PubMed
192. Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int. 2014 Sep; 114 (3):368-74 Epub 2014 Jan 29
     View PubMed
193. Welch BT, Callstrom MR, Carpenter PC, Wass CT, Welch TL, Boorjian SA, Nichols DA, Thompson GB, Lohse CM, Erickson D, Leibovich BC, Atwell TD. A single-institution experience in image-guided thermal ablation of adrenal gland metastases. J Vasc Interv Radiol. 2014 Apr; 25 (4):593-8 Epub 2014 Feb 06
     View PubMed
194. Carrasco A, Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Boorjian SA. The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Indian J Urol. 2014 Jan; 30 (1):38-42
     View PubMed
195. Hallemeier CL, Choo R, Davis BJ, Leibovich BC, Costello BA, Pisansky TM. Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience. Urol Oncol. 2014 Jan; 32 (1):24.e1-6 Epub 2013 Mar 11
     View PubMed
196. Hallemeier CL, Karnes RJ, Pisansky TM, Davis BJ, Gunderson LL, Leibovich BC, Haddock MG, Choo R. Multimodality therapy including surgical resection and intraoperative electron radiotherapy for recurrent or advanced primary carcinoma of the urinary bladder or ureter. Am J Clin Oncol. 2013 Dec; 36(6):596-600.
     View PubMed
197. Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol. 2013 Oct; 64 (4):600-6 Epub 2012 Dec 25
     View PubMed
198. Wang JK, Tollefson MK, Kim SP, Boorjian SA, Leibovich BC, Lohse CM, Cheville JC, Thompson RH. Iatrogenic splenectomy during nephrectomy for renal tumors. Int J Urol. 2013 Sep; 20 (9):896-902 Epub 2013 Feb 04
     View PubMed
199. Kaushik D, Linder BJ, Thompson RH, Eisenberg MS, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis. Urology. 2013 Jul; 82 (1):136-41 Epub 2013 May 01
     View PubMed
200. Eisenberg MS, Cheville JC, Thompson RH, Kaushik D, Lohse CM, Boorjian SA, Costello BA, Leibovich BC. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma. J Urol. 2013 Jul; 190 (1):37-43 Epub 2013 Jan 23
     View PubMed
201. Zhang BY, Thompson RH, Lohse CM, Dronca RS, Cheville JC, Kwon ED, Leibovich BC. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. BJU Int. 2013 Jun; 111 (7):1046-53 Epub 2013 Apr 02
     View PubMed
202. Weight CJ, Kim SP, Jacobson DJ, McGree ME, Boorjian SA, Thompson RH, Leibovich BC, Karnes RJ, St Sauver J. The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. Eur Urol. 2013 Jun; 63(6):1021-7. Epub 2013 Jan 04.
     View PubMed
203. Weight CJ, Crispen PL, Breau RH, Kim SP, Lohse CM, Boorjian SA, Thompson RH, Leibovich BC. Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int. 2013 May; 111 (5):731-8 Epub 2012 Apr 13
     View PubMed
204. Breau RH, Clark E, Bruner B, Cervini P, Atwell T, Knoll G, Leibovich BC. A simple method to estimate renal volume from computed tomography. Can Urol Assoc J. 2013 May-Jun; 7(5-6):189-92.
     View PubMed
205. Kim SP, Leibovich BC, Shah ND, Weight CJ, Borah BJ, Han LC, Boorjian SA, Thompson RH. The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer. BJU Int. 2013 Apr; 111(4):580-8. Epub 2012 May 07.
     View PubMed
206. Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA, Cheville JC. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol. 2013 Mar; 37 (3):311-22
     View PubMed
207. Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Mandrekar J, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE, Lohse CM, Thompson RH. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013 Feb; 200 (2):461-6
     View PubMed
208. Junker K, Ficarra V, Kwon ED, Leibovich BC, Thompson RH, Oosterwijk E. Potential role of genetic markers in the management of kidney cancer. Eur Urol. 2013 Feb; 63(2):333-40. Epub 2012 Sep 24.
     View PubMed
209. Leibovich BC. Pro and extent. J Urol. 2013; 189(2):420-1.
     
210. Kurup AN, Thompson RH, Leibovich BC, Harmsen WS, Sebo TJ, Callstrom MR, Kawashima A, Atwell TD. Renal oncocytoma growth rates before intervention. BJU Int. 2012 Nov; 110 (10):1444-8 Epub 2012 Apr 23
     View PubMed
211. Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol. 2012 Nov; 25 (11):1516-25 Epub 2012 June 29
     View PubMed
212. Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma. BJU Int. 2012 Oct; 110 (7):956-60 Epub 2012 Feb 02
     View PubMed
213. Kim SP, Crispen PL, Thompson RH, Weight CJ, Boorjian SA, Costello BA, Lohse CM, Leibovich BC. Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma. Cancer. 2012 Sep 15; 118 (18):4412-20 Epub 2012 Jan 03
     View PubMed
214. Weight CJ, Kim SP, Karnes RJ, Bergstralh EJ, Cheville JC, Leibovich BC. A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosis. Urology. 2012 Aug; 80(2):484.e17-22. Epub 2012 Apr 13.
     View PubMed
215. Thiel DD, Lohse CM, Arnold ML, Cheville JC, Leibovich BC, Parker AS. Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus? Int Urol Nephrol. 2012 Aug; 44 (4):1005-12 Epub 2012 Apr 13
     View PubMed
216. Jorns JJ, Thiel DD, Lohse C, Williams A, Arnold M, Cheville J, Leibovich B, Parker AS. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma. Urology. 2012 Jul; 80 (1):147-50
     View PubMed
217. Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, Shippee ND, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul; 188 (1):51-7 Epub 2012 May 14
     View PubMed
218. Cheville JC, Lohse CM, Sukov WR, Thompson RH, Leibovich BC. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Am J Surg Pathol. 2012 Jun; 36 (6):851-6
     View PubMed
219. Sukov WR, Hodge JC, Lohse CM, Leibovich BC, Thompson RH, Pearce KE, Wiktor AE, Cheville JC. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients. Am J Surg Pathol. 2012 May; 36 (5):663-70
     View PubMed
220. Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 2012 Apr; 263 (1):160-8 Epub 2012 Feb 17
     View PubMed
221. Hallemeier CL, Choo R, Davis BJ, Pisansky TM, Gunderson LL, Leibovich BC, Haddock MG. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82 (5):1938-43 Epub 2011 Apr 20
     View PubMed
222. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012 Feb; 79 (2):356-60
     View PubMed
223. Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, Thompson RH, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol. 2012 Jan; 23(1):48-54. Epub 2011 Oct 28.
     View PubMed
224. Sukov WR, Lohse CM, Leibovich BC, Thompson RH, Cheville JC. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. J Urol. 2012 Jan; 187 (1):54-9 Epub 2011 Nov 16
     View PubMed
225. Umbreit EC, Shimko MS, Childs MA, Lohse CM, Cheville JC, Leibovich BC, Blute ML, Thompson RH. Metastatic potential of a renal mass according to original tumour size at presentation. BJU Int. 2012 Jan; 109 (2):190-4; discussion 194 Epub 2011 May 09
     View PubMed
226. Inman BA, Frank I, Boorjian SA, Akornor JW, Karnes RJ, Leibovich BC, Blute ML, Bergstralh EJ. Dynamic prediction of metastases after radical prostatectomy for prostate cancer. BJU Int. 2011 Dec; 108: (11)1762-8.
     View PubMed
227. Kim SP, Shah ND, Weight CJ, Thompson RH, Moriarty JP, Shippee ND, Costello BA, Boorjian SA, Leibovich BC. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol. 2011 Nov; 186 (5):1779-85 Epub 2011 Sept 25
     View PubMed
228. Mitchell CR, Atwell TD, Weisbrod AJ, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. J Urol. 2011 Nov; 186 (5):1786-90 Epub 2011 Sept 25
     View PubMed
229. Kim SP, Weight CJ, Leibovich BC, Thompson RH, Costello BA, Cheville JC, Lohse CM, Boorjian SA. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology. 2011 Nov; 78 (5):1101-6 Epub 2011 Sept 08
     View PubMed
230. Margulis V, Master VA, Cost NG, Leibovich BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y, Rawal S, Chong TW, Wood CG. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Eur Urol. 2011 Oct; 60(4):673-83. Epub 2011 Jun 29.
     View PubMed
231. Weight CJ, Atwell TD, Fazzio RT, Kim SP, Kenny M, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes. J Urol. 2011 Oct; 186 (4):1223-8 Epub 2011 Aug 17
     View PubMed
232. Childs MA, Breau RH, Umbreit EC, Lohse CM, Cheville JC, Thompson RH, Blute ML, Leibovich BC. Metachronous renal tumours after surgical management of oncocytoma. BJU Int. 2011 Sep; 108 (6):816-9 Epub 2010 Dec 16
     View PubMed
233. Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Eur Urol. 2011 Sep; 60 (3):458-64 Epub 2011 Apr 16
     View PubMed
234. Bruner B, Breau RH, Lohse CM, Leibovich BC, Blute ML. Renal nephrometry score is associated with urine leak after partial nephrectomy. BJU Int. 2011 Jul; 108 (1):67-72 Epub 2010 Nov 18
     View PubMed
235. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer. 2011 Jul 1; 117 (13):2873-82 Epub 2011 Jan 10
     View PubMed
236. Kim SP, Alt AL, Weight CJ, Costello BA, Cheville JC, Lohse C, Allmer C, Leibovich BC. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol. 2011 Jun; 185 (6):2035-9 Epub 2011 Apr 15
     View PubMed
237. Frigola X, Inman BA, Lohse CM, Krco CJ, Cheville JC, Thompson RH, Leibovich B, Blute ML, Dong H, Kwon ED. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res. 2011 Apr 1; 17 (7):1915-23 Epub 2011 Feb 25
     View PubMed
238. Shuch B, Crispen PL, Leibovich BC, Larochelle JC, Pouliot F, Pantuck AJ, Liu W, Crepel M, Schuckman A, Rigaud J, Bouchot O, Patard JJ, Skinner D, Belldegrun AS, Blute ML. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-8.
     View PubMed
239. Breau RH, Crispen PL, Jenkins SM, Blute ML, Leibovich BC. Treatment of patients with small renal masses: a survey of the American Urological Association. J Urol. 2011 Feb; 185(2):407-13. Epub 2010 Dec 17.
     View PubMed
240. Dozois EJ, Privitera A, Holubar SD, Aldrete JF, Sim FH, Rose PS, Walsh MF, Bower TC, Leibovich BC, Nelson H, Larson DW. High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved? J Surg Oncol. 2011 Feb; 103 (2):105-9 Epub 2010 Dec 22
     View PubMed
241. Kim SP, Shah ND, Weight CJ, Thompson RH, Moriarty JP, Shippee ND, Costello BA, Boorjian SA, Leibovich BC. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: Results from a population based cohort. International Braz J Urol. 2011; 37(5):663.
     
242. Crispen PL, Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, Blute ML. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: Indications and recommendations for surgical templates. International Braz J Urol. 2011; 37(2):280-1.
     
243. Crispen PL, Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, Blute ML. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol. 2011 Jan; 59 (1):18-23 Epub 2010 Sept 15
     View PubMed
244. Welch BT, Atwell TD, Nichols DA, Wass CT, Callstrom MR, Leibovich BC, Carpenter PC, Mandrekar JN, Charboneau JW. Percutaneous image-guided adrenal cryoablation: procedural considerations and technical success. Radiology. 2011 Jan; 258(1):301-7. Epub 2010 Oct 22
     View PubMed
245. Schmit GD, Atwell TD, Leibovich BC, Callstrom MR, Kurup AN, Woodrum DA, Charboneau JW. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety. AJR Am J Roentgenol. 2010 Dec; 195 (6):1418-22
     View PubMed
246. Sasiwimonphan K, Takahashi N, Leibovich BC, Kawashima A. Adrenal hematoma after nephrectomy. AJR Am J Roentgenol. 2010 Dec; 195 (6):1334-7
     View PubMed
247. Tollefson MK, Boorjian SA, Lohse CM, Blute ML, Leibovich BC. The impact of family history on pathological and clinical outcomes in non-syndromic clear cell renal cell carcinoma. BJU Int. 2010 Dec; 106 (11):1638-42
     View PubMed
248. Atwell TD, Callstrom MR, Farrell MA, Schmit GD, Woodrum DA, Leibovich BC, Chow GK, Patterson DE, Blute ML, Charboneau JW. Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol. 2010 Oct; 184(4):1291-5. Epub 2010 Aug 17.
     View PubMed
249. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010 Sep; 58 (3):340-5 Epub 2010 June 09
     View PubMed
250. Crispen PL, Tabidian MR, Allmer C, Lohse CM, Breau RH, Blute ML, Cheville JC, Leibovich BC. Unclassified renal cell carcinoma: impact on survival following nephrectomy. Urology. 2010 Sep; 76 (3):580-6 Epub 2010 Mar 12
     View PubMed
251. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Campbell SC, Blute ML. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 2010 Sep; 58 (3):331-6 Epub 2010 June 09
     View PubMed
252. Schmit GD, Atwell TD, Callstrom MR, Farrell MA, Leibovich BC, Patterson DE, Chow GK, Blute ML, Charboneau JW. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. J Endourol. 2010 Aug; 24: (8)1255-62.
     View PubMed
253. Tollefson MK, Krambeck AE, Leibovich BC, Blute ML, Chow GK. Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. Urology. 2010 Jun; 75(6):1373-7. Epub 2009 Oct 07.
     View PubMed
254. Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010 Apr; 183 (4):1309-15 Epub 2010 Feb 19
     View PubMed
255. Takahashi N, Glockner JF, Hartman RP, King BF, Leibovich BC, Stanley DW, Fitz-Gibbon PD, Kawashima A. Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol. 2010 Apr; 183(4):1330-65. Epub 2010 Feb 19.
     View PubMed
256. Srigley JR, Amin MB, Delahunt B, Campbell SC, Chang A, Grignon DJ, Humphrey PA, Leibovich BC, Montironi R, Renshaw AA, Reuter VE, Members of the Cancer Committee College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med. 2010 Apr; 134(4):e25-30.
     View PubMed
257. Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, Leibovich BC. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol. 2010 Mar; 183 (3):903-8 Epub 2010 Jan 18
     View PubMed
258. Kayalar N, Leibovich BC, Orszulak TA, Schaff HV, Sundt TM, Daly RC, McGregor CG. Concomitant surgery for renal neoplasm with pulmonary tumor embolism. J Thorac Cardiovasc Surg. 2010 Feb; 139: (2)320-5.
     View PubMed
259. Froemming A, Atwell T, Farrell M, Callstrom M, Leibovich B, Charboneau W. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol. 2010 Jan; 21 (1):148-51
     View PubMed
260. Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol. 2009 Dec; 182 (6):2601-6 Epub 2009 Oct 17
     View PubMed
261. Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Leibovich BC, Kwon ED. T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. Urology. 2009 Dec; 74 (6):1359-64 Epub 2009 June 07
     View PubMed
262. Baden J, Green G, Painter J, Curtin K, Markiewicz J, Jones J, Astacio T, Canning S, Quijano J, Guinto W, Leibovich BC, Nelson JB, Vargo J, Wang Y, Wuxiong C. Multicenter evaluation of an investigational prostate cancer methylation assay. J Urol. 2009 Sep; 182(3):1186-93. Epub 2009 Jul 21.
     View PubMed
263. Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol. BJU Int. 2009 Sep; 104 (6):778-85 Epub 2009 Mar 11
     View PubMed
264. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol. 2009 Aug; 182(2):517-25; discussion 525-7. Epub 2009 Jun 13.
     View PubMed
265. Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED. Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer. 2009 May 15; 115 (10):2092-103
     View PubMed
266. Gettman MT, Pereira CW, Lipsky K, Wilson T, Arnold JJ, Leibovich BC, Karnes RJ, Dong Y. Use of high fidelity operating room simulation to assess and teach communication, teamwork and laparoscopic skills: initial experience. J Urol. 2009 Mar; 181 (3):1289-96 Epub 2009 Jan 18
     View PubMed
267. Bruner B, Ashley R, Leibovich B, Blute M, LeRoy A. Case report: percutaneous catheter management of persistent urine leak due to iatrogenic infundibular stenosis after partial nephrectomy. J Endourol. 2009 Jan; 23: (1)37-41.
     View PubMed
268. Leibovich BC, Blute ML. Lymph node dissection in the management of renal cell carcinoma. Urol Clin North Am. 2008 Nov; 35(4):673-8; viii.
     View PubMed
269. Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC. Outcomes following partial nephrectomy by tumor size. J Urol. 2008 Nov; 180 (5):1912-7 Epub 2008 Sept 17
     View PubMed
270. Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Urol. 2008 Oct; 180(4 Part 1):1302.
     
271. Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Kwon ED, Leibovich BC. Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology. 2008 Oct; 72 (4):927-32 Epub 2008 Mar 28
     View PubMed
272. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol. 2008 Oct; 54 (4):855-63 Epub 2008 May 09
     View PubMed
273. Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, Karnes RJ, Leibovich BC. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. Cancer. 2008 Oct 1; 113 (7):1544-51
     View PubMed
274. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res. 2008 Aug 15; 14 (16):5150-7 Epub 2008 Aug 11
     View PubMed
275. Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res. 2008 Aug 1; 68 (15):6054-8
     View PubMed
276. Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res. 2008 Aug 1; 14 (15):4800-8
     View PubMed
277. Parker AS, Lohse CM, Leibovich BC, Cheville JC, Sheinin YM, Kwon ED. Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma. Hum Pathol. 2008 Aug; 39 (8):1176-84 Epub 2008 June 05
     View PubMed
278. Routh JC, Bacon DR, Leibovich BC, Zincke H, Blute ML, Frank I. How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery. BJU Int. 2008 Aug; 102 (3):301-4 Epub 2008 Apr 11
     View PubMed
279. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer. 2008 Aug 1; 113 (3):450-60
     View PubMed
280. Gettman MT, Karnes RJ, Arnold JJ, Klipfel JM, Vierstraete HT, Johnson ME, Johnson DR, Leibovich BC. Urology resident training with an unexpected patient death scenario: experiential learning with high fidelity simulation. J Urol. 2008 Jul; 180(1):283-8; discussion 288. Epub 2008 May 21.
     View PubMed
281. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol. 2008 Jul; 180 (1):99-103; discussion 103 Epub 2008 May 15
     View PubMed
282. Granberg CF, Boorjian SA, Schaff HV, Orszulak TA, Leibovich BC, Lohse CM, Cheville JC, Blute ML. Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass. Urology. 2008 Jul; 72 (1):148-52 Epub 2008 Apr 18
     View PubMed
283. Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int. 2008 Jun; 101(11):1375-9.
     View PubMed
284. Atwell TD, Farrell MA, Leibovich BC, Callstrom MR, Chow GK, Blute ML, Charboneau JW. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008 Jun; 179(6):2136-40; discussion 2140-1.
     View PubMed
285. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol. 2008 Jun; 179(6):2146-51; discussion 2151. Epub 2008 Apr 18.
     View PubMed
286. Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol. 2008 Jun; 179(6):2158-63.
     View PubMed
287. Takahashi N, Kawashima A, Glockner JF, Hartman RP, Leibovich BC, Brau AC, Beatty PJ, King BF. Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology. 2008 May; 247(2):451-7. Epub 2008 Mar 27.
     View PubMed
288. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol. 2008 May; 179(5 Suppl):S7-S11.
     View PubMed
289. Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B, Robin H, Pelzer A, Schafer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A. Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem. 2008 May; 54(5):874-82. Epub 2008 Mar 13.
     View PubMed
290. Parker A, Lohse C, Cheville J, Leibovich B, Igel T, Blute M. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol. 2008 Apr; 15 (4):304-8
     View PubMed
291. Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer. 2008 Apr 1; 112 (7):1471-9
     View PubMed
292. Thompson RH, Leibovich BC, Karnes RJ, Bergstralh EJ, Blute ML. Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol. 2008 Apr; 179 (4):1349-52; discussion 1352-3 Epub 2008 Mar 04
     View PubMed
293. Inman BA, Frigola X, Harris KJ, Kuntz SM, Lohse CM, Leibovich BC, Kwon ED. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol. 2008 Mar 1; 180 (5):3578-84
     View PubMed
294. Magera JS Jr, Frank I, Lohse CM, Leibovich BC, Cheville JC, Blute ML. Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol. 2008 Mar; 179 (3):853-6 Epub 2008 Jan 25
     View PubMed
295. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008 Feb; 179 (2):468-71; discussion 472-3
     View PubMed
296. Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol. 2008 Feb; 179 (2):474-7
     View PubMed
297. Magera JS Jr, Leibovich BC, Lohse CM, Sengupta S, Cheville JC, Kwon ED, Blute ML. Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. Urology. 2008 Feb; 71 (2):278-82
     View PubMed
298. Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. BJU Int. 2008 Jan; 101(2):170-4.
     View PubMed
299. Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology. 2007 Dec; 70 (6):1064-8
     View PubMed
300. Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology. 2007 Nov; 70 (5):900-4; discussion 904
     View PubMed
301. Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol. 2007 Oct 20; 25 (30):4757-64
     View PubMed
302. Granberg CF, Krambeck AE, Leibovich BC, Frank I, Lohse CM, Gettman MT, Blute ML, Chow GC. Potential underdetection of pT(3a) renal-cell carcinoma with laparoscopic morcellation. J Endourol. 2007 Oct; 21 (10):1183-6
     View PubMed
303. Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer. 2007 Aug 15; 110 (4):783-90
     View PubMed
304. Leibovich BC. Predicting RCC outcomes: an update. Renal & Urology News Aug. 2007 Aug; 6(8):20-2.
     
305. Thompson RH, Blute ML, Slezak JM, Bergstralh EJ, Leibovich BC. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? J Urol. 2007 Aug; 178(2):459-63; discussion 463. Epub 2007 Jun 11.
     View PubMed
306. Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol. 2007 Aug; 178 (2):440-5; discussion 444 Epub 2007 June 11
     View PubMed
307. Thompson RH, Blute ML, Krambeck AE, Lohse CM, Magera JS, Leibovich BC, Kwon ED, Frank I, Cheville JC. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol. 2007 Jul; 31 (7):1089-93
     View PubMed
308. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Frank I, Patterson DE. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007 May; 188: (5)1195-200.
     View PubMed
309. Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE, Sengupta S, Dong H, Cheville JC, Lohse CM, Krco CJ, Webster WS, Leibovich BC, Blute ML, Knutson KL, Kwon ED. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res. 2007 Apr 1; 13 (7):2075-81
     View PubMed
310. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Patterson DE, Chow GK, Blute ML. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology. 2007 Apr; 243 (1):276-83 Epub 2007 Feb 28
     View PubMed
311. Tollefson MK, Slezak JM, Leibovich BC, Zincke H, Blute ML. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc. 2007 Apr; 82(4):422-7.
     View PubMed
312. Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin Cancer Res. 2007 Mar 15; 13 (6):1749-56
     View PubMed
313. Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res. 2007 Mar 15; 13 (6):1757-61
     View PubMed
314. Thompson RH, Frank I, Lohse CM, Saad IR, Fergany A, Zincke H, Leibovich BC, Blute ML, Novick AC. The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol. 2007 Feb; 177 (2):471-6
     View PubMed
315. Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, Frank I. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. J Urol. 2007 Feb; 177 (2):477-80
     View PubMed
316. Tollefson MK, Takahashi N, Leibovich BC. Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma. Curr Urol Rep. 2007 Jan; 8 (1):38-43
     View PubMed
317. Siddiqui SA, Frank I, Leibovich BC, Cheville JC, Lohse CM, Zincke H, Blute ML. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. J Urol. 2007 Jan; 177 (1):59-62
     View PubMed
318. Krambeck AE, Leibovich BC, Lohse CM, Kwon ED, Zincke H, Blute ML. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. J Urol. 2006 Nov; 176 (5):1990-5; discussion 1995
     View PubMed
319. Dimashkieh HH, Lohse CM, Blute ML, Kwon ED, Leibovich BC, Cheville JC. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol. 2006 Nov; 176 (5):1978-82; discussion 1982-3
     View PubMed
320. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 2006 Oct; 68 (4):741-6
     View PubMed
321. Leibovich BC, Blute ML. Surgical management of renal cell carcinoma. Semin Oncol. 2006 Oct; 33(5):552-62.
     View PubMed
322. Routh JC, Crimmins CR, Leibovich BC, Elliott DS. Impact of Parkinson's disease on continence after radical prostatectomy. Urology. 2006 Sep; 68(3):575-7. Epub 2006 Sep 18.
     View PubMed
323. Inman BA, DiMarco DS, Slezak JM, Sebo TJ, Kwon ED, Leibovich BC, Blute ML, Zincke H. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology. 2006 Sep; 68(3):604-8. Epub 2006 Sep 18.
     View PubMed
324. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Zincke H, Blute ML. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol. 2006 Sep; 176 (3):900-3; discussion 903-4
     View PubMed
325. Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006 Aug 15; 107(4):712-20.
     View PubMed
326. Sengupta S, Christensen CM, Zincke H, Slezak JM, Leibovich BC, Bergstralh EJ, Myers RP, Blute ML. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. J Urol. 2006 Aug; 176(2):559-63.
     View PubMed
327. Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer. 2006 Aug 1; 107(3):521-9.
     View PubMed
328. Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A. 2006 Jul 5; 103 (27):10391-10396 Epub 2006 June 23
     View PubMed
329. Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer. 2006 Jul 1; 107 (1):37-45
     View PubMed
330. Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival. Cancer. 2006 Jul 1; 107 (1):46-53
     View PubMed
331. Sengupta S, Slezak JM, Blute ML, Leibovich BC, Sebo TJ, Myers RP, Cheville JC, Bergstralh EJ, Zincke H. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer. 2006 Jun 15; 106(12):2630-5.
     View PubMed
332. Sengupta S, Blute ML, Bagniewski SM, Myers RP, Bergstralh EJ, Leibovich BC, Zincke H. Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. J Urol. 2006 May; 175(5):1684-90; discussion 1690.
     View PubMed
333. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006 Apr 1; 66 (7):3381-5
     View PubMed
334. Siddiqui SA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Myers RP, Zincke H, Blute ML. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol. 2006 Mar; 175 (3 Pt 1):952-7
     View PubMed
335. Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol. 2006 Feb; 175 (2):547-51
     View PubMed
336. Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer. 2006 Jan 15; 106 (2):304-12
     View PubMed
337. Sengupta S, Cheville JC, Corless CL, Lohse CM, Heinrich MC, Kwon ED, Zincke H, Blute ML, Leibovich BC. Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. J Urol. 2006 Jan; 175 (1):53-6
     View PubMed
338. Webster WS, Leibovich BC. Exisulind in the treatment of prostate cancer. Expert Rev Anticancer Ther. 2005 Dec; 5(6):957-62.
     View PubMed
339. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma. Cancer. 2005 Nov 15; 104 (10):2084-91
     View PubMed
340. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol. 2005 Nov; 174 (5):1759-63; discussion 1763
     View PubMed
341. Thompson RH, Webster WS, Cheville JC, Lohse CM, Dong H, Leibovich BC, Kuntz SM, Sengupta S, Kwon ED, Blute ML. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. Urology. 2005 Nov; 66 (5 Suppl):10-4
     View PubMed
342. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 2005 Oct; 174 (4 Pt 1):1218-21
     View PubMed
343. Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol. 2005 Sep; 174 (3):855-8
     View PubMed
344. Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC, Kwon ED. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005 Aug 1; 104 (3):511-20
     View PubMed
345. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res. 2005 Jul 15; 11 (14):5128-39
     View PubMed
346. Sengupta S, Leibovich BC, Blute ML, Zincke H. Surgery for metastatic renal cell cancer. World J Urol. 2005 Jul; 23 (3):155-60 Epub 2005 June 30
     View PubMed
347. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol. 2005 Jul; 174 (1):107-10; discussion 110-1
     View PubMed
348. Sengupta S, Zincke H, Leibovich BC, Blute ML. Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series. BJU Int. 2005 Jul; 96(1):54-7.
     View PubMed
349. Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer. 2005 Jul 1; 104 (1):53-60
     View PubMed
350. Routh JC, Leibovich BC. Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease. Mayo Clin Proc. 2005 Jul; 80(7):899-907.
     View PubMed
351. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol. 2005 Jun; 173 (6):1889-92
     View PubMed
352. Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, Zincke H, Blute ML. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol. 2005 Jun; 173 (6):1893-6
     View PubMed
353. Parker AS, Cheville JC, Lohse CM, Igel T, Leibovich BC, Blute ML. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma. Urology. 2005 Jun; 65 (6):1090-5
     View PubMed
354. Chrouser KL, Leibovich BC, Sweat SD, Larson DW, Davis BJ, Tran NV, Zincke H, Blute ML. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol. 2005 Jun; 173(6):1953-7.
     View PubMed
355. Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol. 2005 Mar; 173 (3):918-21
     View PubMed
356. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol. 2005 Mar; 173 (3):716-9
     View PubMed
357. Routh JC, Lischer GH, Leibovich BC. Epididymo-orchitis and testicular abscess due to Nocardia asteroides complex. Urology. 2005 Mar; 65(3):591.
     View PubMed
358. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Kwon ED, Zincke H. pT2 classification for renal cell carcinoma. Can its accuracy be improved? J Urol. 2005 Feb; 173 (2):380-4
     View PubMed
359. Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol. 2005 Feb; 173 (2):391-4
     View PubMed
360. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED. Aberrant expression of costimulatory B7-H1 in clear cell renal cell carcinoma. The American Journal of Urology Review. 2005; 3(5):244-9.
     
361. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A. 2004 Dec 7; 101 (49):17174-9 Epub 2004 Nov 29
     View PubMed
362. Kwon E, Thompson RH, Gillett M, Cheville J, Lohse C, Dong H, Webster WS, Krejci K, Lobo J, Sengupta S, Leiping C, Zincke H, Blute ML, Strome S, Leibovich BC. Immune cell marker expressed in kidney cancer and predicts aggressiveness. Cancer Biology and Therapy. 2004 Dec; 3(12):1199.
     
363. Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED. Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol. 2004 Nov 15; 173 (10):6098-108
     View PubMed
364. Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol. 2004 Aug; 172 (2):465-9
     View PubMed
365. Miller DV, McClure RF, Crawford BG, Zeldenrust SR, Leibovich BC, Sebo TJ. Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA kappa plasmacytoma of the bladder. Diagn Cytopathol. 2004 Jul; 31(1):48-51.
     View PubMed
366. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004 Jul; 94 (1):33-41
     View PubMed
367. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, Blute ML. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004 Apr; 28 (4):435-41
     View PubMed
368. Mosharafa AA, Foster RS, Leibovich BC, Ulbright TM, Bihrle R, Einhorn LH, Donohue JP. Histology in mixed germ cell tumors. Is there a favorite pairing? J Urol. 2004 Apr; 171:1741-3.
     
369. Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol. 2004 Mar; 171 (3):1066-70
     View PubMed
370. Thompson RH, Hartman RP, Lowe VJ, Kawashima A, Leibovich BC. Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses. Curr Urol Rep. 2004 Feb; 5 (1):30-4
     View PubMed
371. Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP. History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol. 2004 Jan 1; 159 (1):42-8
     View PubMed
372. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Leibovich BC, Zincke H. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol. 2003 Dec; 170 (6 Pt 1):2225-32
     View PubMed
373. Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. J Urol. 2003 Sep; 170 (3):760-3
     View PubMed
374. Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol. 2003 Jun; 169(6):2126-28.
     View PubMed
375. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003 Apr 1; 97 (7):1663-71
     View PubMed
376. Davis BJ, Pisansky TM, Leibovich BC. Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer. Curr Opin Urol. 2003 Mar; 13 (2):117-22
     View PubMed
377. Krejci KG, Leibovich BC. Should there be a size limit for elective nephron-sparing surgery? Curr Urol Rep. 2003 Feb; 4 (1):21-9
     View PubMed
378. Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003; 98:2566-2577.
     View PubMed
379. Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology. 2003; 61(314-319).
     View PubMed
380. Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, Dorey FJ, Zisman A, Janzen NK, Mukouyama H, Figlin RA, et al. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. (Includes discussion p.903-904). J Urol. 2003; 169:899-904.
     View PubMed
381. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res. 2003; 9:802-811.
     View PubMed
382. Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 2002 Sep 15; 95 (6):1215-9
     View PubMed
383. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001 Jul; 166 (1):86-91; discussion 91-2
     View PubMed
384. Leibovich BC, Blute ML, Bostwick DG, Wilson TM, Pisansky TM, Davis BJ, Ramnani DM, Cheng L, Sebo TJ, Zincke H. Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology. 2000 Nov 1; 56 (5):726-9
     View PubMed
385. Leibovich BC, Cheng L, Weaver AL, Myers RP, Bostwick DG. Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer. J Urol. 2000 Jun; 163 (6):1756-60
     View PubMed
386. Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 2000 May 15; 88(10):2326-32.
     View PubMed
387. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H, Bostwick DG. The cell cycle inhibitors p21(WAF1) and p27(KIP1) are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res. 2000 May; 6(5):1896-1899.
     View PubMed
388. Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol. 2000 Apr; 163(4):1178-82.
     View PubMed
389. Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Nehra A, Malek RS, Zincke H, Bostwick DG. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer. 2000 Apr 1; 88(7):1679-86.
     View PubMed
390. Cheng L, Leibovich BC, Cheville JC, Ramnani DM, Sebo TJ, Neumann RM, Nascimento AG, Zincke H, Bostwick DG. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer. 2000 Feb 15; 88(4):844-52.
     View PubMed
391. Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H, Bostwick DG. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol. 2000 Feb; 113(2):275-9.
     View PubMed
392. Cheng L, Pisansky TM, Ramnani DM, Leibovich BC, Cheville JC, Slezak J, Bergstralh EJ, Zincke H, Bostwick DG. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000 Feb; 13(2):113-8.
     View PubMed
393. Cheng L, Pisansky TM, Sebo TJ, Leibovich BC, Ramnani DM, Weaver AL, Scherer BG, Blute ML, Zincke H, Bostwick DG. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. Clin Cancer Res. 1999 Oct; 5(10):2820-3.
     View PubMed
394. Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG. Neurofibroma of the urinary bladder. Cancer. 1999 Aug 1; 86(3):505-13.
     View PubMed
395. Cheng L, Nascimento AG, Neumann RM, Nehra A, Cheville JC, Ramnani DM, Leibovich BC, Bostwick DG. Hemangioma of the urinary bladder. Cancer. 1999 Aug 1; 86(3):498-504.
     View PubMed
396. Cheng L, Neumann RM, Scherer BG, Weaver AL, Leibovich BC, Nehra A, Zincke H, Bostwick DG. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer. 1999 Jun 15; 85(12):2638-47.
     View PubMed
397. Cheng L, Leibovich BC, Bergstralh EJ, Scherer BG, Pacelli A, Ramnani DM, Zincke H, Bostwick DG. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer. 1999 Jun 1; 85(11):2455-9.
     View PubMed
398. Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Bostwick DG. Survival of patients with carcinoma in situ of the urinary bladder. Cancer. 1999 Jun 1; 85(11):2469-74.
     View PubMed
399. Amling CL, Leibovich BC, Lerner SE, Bergstralh EJ, Blute ML, Myers RP, Zincke H. Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate. Semin Urol Oncol. 1997 Nov; 15(4):215-21.
     View PubMed
400. Leibovich BC, Barrett DM. Use of the artificial urinary sphincter in men and women. World J Urol. 1997; 15 (5):316-9
     View PubMed
401. Kallakury BVS, Figge J, Leibovich BC, Hwang J, Rifkin M, Kaufman R, Figge H, Nazeer T, Ross JS. Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2. 8 kb major breakpoint region or with P53 protein accumulation Modern Pathology. 1996; 9(1):41-7.